EAGAN, Minn.--(BUSINESS WIRE)--Biothera, a privately held biotechnology company, announced today that its lead drug candidate, Imprime PGG®, has been named one of the Top 10 Most Interesting Oncology Projects Available for Partnering by Windhover Information Inc. in conjunction with an independent expert advisory group, Campbell Alliance.
